Back

Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes

25 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (1) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Bochra Zareini

Nordsjaellands Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study
Professor S. Verma (Toronto, CA)
Abstract Slides
Presentation thumbnail
Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy
Associate Professor S. Timpka (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
The prognostic value of high-sensitivity cardiac troponin t in diabetes patients without coronary artery disease
Mr Y. He (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between intensity of glycemic control with GLP-1 receptor agonists and risk of atherosclerotic cardiovascular disease: a systematic review and meta-regression
thumbnail
Congress Presentation
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
thumbnail
Congress Presentation
Association of HbA1C with mortality and cardiovascular outcome in patients with type 2 diabetes using drugs with different hypoglycemic risk